Plavix上市20多年，已治疗超过2亿患者。此次批准，Plavix+阿司匹林可用于治疗中高危短暂性缺血性发作(TIA)或轻微缺血性卒中(IS)成人患者。

波立维（Plavix）是百时美施贵宝公司（BMY）出品的抗凝血药物，一直以来许多制药商都试图生产出售Plavix的仿制药，以从其巨大利润中分一杯羹。 FDA ...

Tuesday morning, shareholders in Bristol-Myers Squibb and Sanofi-Aventis woke up to a sucker punch. Bristol, in its quarterly report, announced that a generic knockoff of Plavix, a best seller for ...

The Medicines Co., which six months ago stopped two likely-to-fail Phase III trials of antiplatelet drug cangrelor, is out to prove its frog of a drug may be a prince after all.

Doctors have expressed surprise at studies indicating some common heartburn drugs can interfere with Plavix, the world's most-widely used drug to prevent blood clots, WSJ's Alicia Mundy reports.

Aug. 5 -- MONDAY, Aug. 4 (HealthDay News) -- The widely used anti-clotting drug Plavix appears to have a stronger effect in people who smoke, a study indicates. Plavix (clopidogrel) is often given ...

Patients given the blood-clot preventer Plavix after a heart attack or after receiving a stent have a far higher risk of heart attack or death in the three months after they stop taking the drug ...

Stent patients who take the blood thinner Plavix along with certain heartburn drugs may face a greater risk of heart attack, stroke and other dangerous events, according to a study released Tuesday.

Plavix, the blockbuster anti-clotting drug, is ineffective in up to a third of patients. Ron Winslow on Lunch Break looks at whether upping the dosage will allow the drug to work for these people.